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Abstract   
Fc/R (CD351) is an Fc receptor for both IgA and IgM, which is abundantly 
expressed in the small intestine. However, the role of Fc/R in the intestinal tissue is 
largely unknown. Here, we found that Fc/R is highly expressed on follicular 
dendritic cells (FDCs) in Peyer’s patches (PP) in the small intestine. Fc/R-deficient 
mice on the (129 x C57BL/6) F1 background showed increased serum, but not fecal, 
IgA level in response to gut-oriented antigens. IgA+ B cells were increased in PP, but 
not in the lamina propria, of Fc/R-deficient mice, which was attenuated after 
reduction of commensal microbiota by oral treatment with antibiotics. Analyses of bone 
marrow chimeric mice, in which either FDCs or blood cells or both lack the expression 
of Fc/R, suggested that FDCs, but not blood cells, were responsible for the increased 
serum IgA concentration in Fc/R-deficient mice. Moreover, Fc/R-deficient mice 
showed enhanced germinal center formation against commensal microbiota in PP. Thus, 
serum IgA production against gut-oriented antigens is negatively regulated by Fc/R 
on FDCs in the F1 mice.  
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1. Introduction 
IgA is an antibody produced most abundantly among the classes of 
immunoglobulins and mainly secreted to the mucosal lumen (Kerr et al, 1990; 
Macpherson et al, 2012). Secreted IgA prevents penetration of pathogens into the 
mucosal lumen, neutralizes toxins and pathogens (Monteiro & Van De Winkel, 2003), 
and anchors the pathogenic bacteria to the mucus, leading to down-modulation of their 
pro-inflammatory epitopes (Fernandez et al, 2003). In Peyer’s patches (PP), 
antigen-stimulated B cells form germinal centers (GC) with T cell help, leading to class 
switch recombination to IgA (IgA-CSR) in the presence of IgA-CSR-inducing factors, 
such as TGF-and retinoic acid(Cazac & Roes, 2000). IgA+ B cells then circulate 
through the bloodstream and home to the intestinal lamina propria via expressions of 
integrin and CCR9 (Mora & von Andrian, 2009). In addition, IgA+ B cells are 
also generated in the intestinal lamina propria (Fagarasan & Honjo, 2004). These in situ 
IgA-CSR does not require T cells, but does DC (Litinskiy et al, 2002) or epithelial cells 
(Xu et al, 2007), which secrete IgA-CSR-inducing factors (He et al, 2007). IgA 
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produced in the lamina propria is transported and secreted into the mucosal lumen via 
binding to polymeric Ig receptor (pIgR) expressed on the mucosal epithelial cells 
(Kaetzel, 2005). Although the molecular mechanisms for IgA secretion into the mucosal 
lumen have well been studied, little is known about the maintenance of IgA in the sera. 
Fc receptors are expressed on immune cells and play pivotal roles in immune 
responses. Several Fc receptors for IgG [FcRI (CD64), FcRII (CD32), FcRIII 
(CD16) and FcRIV] and IgE [FcRI and FcRII (CD23)] have been identified and 
shown to be pivotal for host immunity, allergy and autoimmune diseases (Ravetch, 
1997), (Takai, 2002). We have previously identified an Fc receptor for both IgA and 
IgM (Fc/R) (Shibuya et al, 2000). Fcamr that encodes Fc/R was mapped on 
chromosome 1, in which other Fc receptor genes are closely located each other (Shibuya 
et al, 2000; Shimizu et al, 2001). Although Fc/R is abundantly expressed in the small 
intestine (Sakamoto et al, 2001), its role in the mucosal tissue is largely unknown. Here, 
we found that Fc/R was preferentially expressed on FDCs in PP and negatively 
regulate the serum IgA level in response to gut-oriented antigens.  
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2.Methods 
2.1 Mice 
Two lines of FcR-deficient mice were generated, as described previously 
(Honda et al, 2009). One line was E14 ES origin and backcrossed to one generation to 
C57BL/6J mice [FcR-deficient mice on (129 x C57BL/6) F1 genetic background]. 
Another line was BALB/c ES origin and then backcrossed to C57BL/6J mice for more 
than twelve generations [FcR-deficient mice on BALB/c and C57BL/6 genetic 
backgrounds, respectively]. BALB/c and C57BL/6J mice were purchased from Clea 
Japan, inc. (Tokyo, Japan). These mice were maintained under the specific pathogen 
free (SPF) condition. For antibiotics treatment, mice were fed with drinking water 
containing ampicillin 1 g/L, neomycin 1 g/L, vancomycin 0.5 g/L and metronidazole 
0.5 g/L for four weeks (Rakoff-Nahoum et al, 2004). All experiments were performed in 
accordance with the guidelines of the animal ethics committee of the University of 
Tsukuba Animal Research Center. 
 
2.2 Antibodies 
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FcR-specific monoclonal antibody (mAb) (TX61) was established 
previously (Cho et al, 2006). TNP-specific mouse IgA (MOPC315) was purchased from 
Cappel (Solon, OH､USA). mAbs against B220 (RA3-6B2), CD21/35 (7G6), CD45 
(30-F11), CD138 (281-2), IgA (C10-3), and T- and B- cell activating antigen (GL-7) 
were purchased from Pharmingen (San Diego, CA, USA). 
 
2.3 Immunization 
Eight- to twelve-week-old FcR-deficient mice of (129 x C57BL/6) F1 
background and wild-type littermate were immunized p.o. via gastric tubes with 1 mg of 
ovalubumin (OVA, Sigma, St. Louis, MO, USA) mixed with 10 g of cholera toxin 
(List Biological Laboratories, Inc., Campbell, CA, USA) once a week for three 
consecutive weeks, or with 50 g of NP-LPS (Biosearch Technologies, Inc., Novato, 
CA, USA) once a week for five consecutive weeks. One week after the final 
immunization, sera and fecal contents were obtained, as described (Shi et al, 1999).   
 
2.4 ELISA 
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Serum and fecal antibody concentrations were measured by ELISA by using 
HRP-conjugated anti-mouse Ig isotype Abs (Southern Biotechnologies, Birmingham, 
AL, USA) and ABTS substrate (BioFX laboratories, Owings Mills, MD, USA). For 
measurement of anti-OVA Abs, plates were coated with OVA and serially diluted sera or 
fecal extract were added, and developed with HRP-conjugated anti-mouse IgA Ab. Ab 
titers were determined by the dilution factor which showed OD405 twice as high as that 
of the background. For measurement of anti-NP Abs, plates were coated with 
NP-conjugated bovine serum albumin, and were developed with HRP-conjugated 
anti-mouse IgA Ab. For measurement of TNP-specific mouse IgA mAb concentration, 
plates were coated with TNP-conjugated OVA and were developed with 
HRP-conjugated anti-mouse IgA Ab.   
 
2.5 Analyses for IgA clearance  
After injection of 50 g TNP-specific mouse IgA (MOPC315) via tail vein, 
sera were collected at indicated time point, and measured for TNP-specific mouse IgA 
concentration by ELISA, as described above. 
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2.6 Cell preparation 
Cells were harvested from the bone marrow (BM), spleen, mesenteric lymph 
node (MLN), Peyer’s patch (PP), peritoneal exudate cell (PEC) and lamina propria (LP) 
one week after intragastric injection of 100 g of LPS. LP cells were prepared, as 
previously described with minor modification (Hurst et al, 1999). Briefly, after PPs 
were excised, intestines were cut into small pieces and digested with dithiothreitol 
(DTT), followed by collagenase type VIII (Sigma, St. Louis, MO, USA). Cells were 
collected from the digested tissues by using centrifugation with 100 %-40 % Percoll. 
 
2.7 Flow cytometry analyses 
The cells were stained with cychrome-conjugated anti-B220 and 
PE-conjugated anti-CD138 mAbs, followed by FITC-conjugated anti-mouse IgA mAb 
after permeabilization with Fix & Perm kit (Invitrogen, Carlsbad, CA, USA). LP cells 
were stained with biotin-conjugated anti-CD45 mAb, followed by APC-conjugated 
streptavidin with cychrome-conjugated anti-B220 mAb. Cells were then permeabilized 
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and stained with FITC-conjugated anti-mouse IgA mAb. For analyses of germinal 
center (GC) B cells, cells were stained with FITC-conjugated GL7 mAb, PE-conjugated 
anti-B2200 mAb and biotin-conjugated-PNA, followed by APC-conjugated streptavidin. 
Cells were analyzed on a FACS Calibur (BD, Franklin Lakes, NJ, USA). 
 
2.8 Immunohistochemistry 
For staining GC, frozen sections were stained with biotin-conjugated PNA, 
followed by Alexa594-conjugated streptavidin with FITC-conjugated anti-CD21/35 
mAb. For staining FcR, frozen sections were stained with biotin-conjugated 
anti-FcR mAb (TX61), followed by HRP-conjugated streptavidin with TSA 
amplification reagent (PerkinElmer, Wellesley, MA, USA) in combination with 
APC-conjugated anti-CD21/35 mAb. 
 
2.9 Bone marrow chimeric mice 
Bone marrow (BM) cells (1 x 107 cells) from FcR-deficient mice or 
wild-type littermate mice were injected intravenously via tail vein into lethally 
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irradiated (2 x 0.55 Gy) FcR-deficient or control mice. Eight weeks after BM cells 
transfer, the blood lymphocytes were analyzed to confirm the engraftment of donor BM 
cells and used for analyses. 
 
2.10 Statistics 
Statistical analyses ware performed by using unpaired Student’s t-test. The 
Smirnov-Grubbs test was used to exclude outliers. 
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3. Results 
3.1  Increased serum IgA in Fc/R-deficient mice on the (129 x C57BL/6) F1 
genetic background.  
Previous reported demonstrated that Fcamr transcript was abundantly 
expressed in the small intestine (Sakamoto et al, 2001). By using immunohistochemical 
analyses, we observed that Fc/R was strongly expressed on FDCs in Peyer’s patches 
(PP) of the small intestine (Fig. 1A). Since FDCs are involved in mucosal IgA 
production (Suzuki et al, 2010), IgA concentration in the serum and feces was analyzed. 
We found that serum IgA was significantly increased in Fc/R-deficient mice on the 
(129 x C57BL/6) F1 genetic background compared with that of littermate control mice 
(Fig. 1B). In contrast, IgA in feces and other immunoglobulin isotypes in serum of 
Fc/R-deficient mice were comparable to those of littermate control mice (Fig. 1C and 
data not shown). However, both Fc/R-deficient mice on the BALB/c and C57BL/6 
genetic backgrounds showed comparable serum IgA levels to respective control mice 
(Fig. 1B). These results suggested that serum IgA level of Fc/R-deficient mice seems 
to be influenced by the genetic background of mice. For further analyses, we used 
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Fc/R-deficient mice on the (129 x C57BL/6) F1 background and their littermates as a 
control. We speculated that serum IgA level was increased in response to gut-oriented 
antigens in Fc/R-deficient mice. To test this possibility, IgA production was analyzed 
after oral immunization of OVA and NP-LPS, T cell-dependent and independent type 
antigens, respectively. In response to both OVA and NP-LPS, antigen-specific IgA titer 
in the sera was significantly increased in Fc/R-deficient mice compared with that of 
control mice (Fig. 1D). In contrast, antigen-specific IgA titer in feces was comparable 
between Fc/R-deficient and control mice (Fig. 1E). These results indicated that 
serum, but not fecal, IgA titers in response to gut-oriented antigens were increased in 
Fc/R-deficient mice on the (129 x C57BL/6) F1 background. In the current study, we 
therefore focused on this genotype of mice to clarify how serum IgA is increased.  
 
3.2  Normal IgA clearance in Fc/R-deficient mice.  
In mice lacking pIgR or J chain, serum IgA is increased as a result of impaired 
IgA transfer from the blood to the bile (Johansen et al, 1999). We speculated that 
increased serum IgA level in Fc/R-deficient mice might be a result of impaired IgA 
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clearance. To address this question, anti-TNP mouse IgA was intravenously injected into 
Fc/R-deficient and control mice, and then measured for its concentration in the sera. 
Anti-TNP mouse IgA concentration was declined with time, and the half life in the sera 
was comparable between Fc/R-deficient and control mice (Fc/R-deficient mice, 
14.7 hours and control mice, 13.3 hours, respectively) (Fig. 1F). Thus, the increased 
serum IgA in Fc/R-deficient mice did not result from impaired IgA clearance from 
the serum. Rather, the production of IgA might be increased in Fc/R-deficient mice.  
 
3.3  Increased IgA+ B cell populations in PP of Fc/R-deficient mice. 
To determine whether IgA production in response to gut-oriented antigens is 
increased in Fc/R-deficient mice, IgA+ B cell population of lymphoid organs were 
analyzed by flow cytometry. We observed that IgA+ B cell population (B220+, IgA+) 
was significantly larger in PPs in Fc/R-deficient mice than those in control mice (Fig. 
2A). In contrast, IgA producing plasma cell population (B220-, IgA+) in lamina propria 
was comparable between Fc/R-deficient and control mice (Fig. 2A). We assumed 
that IgA+ B cell generation might be increased in PP in response to commensal 
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microbiota in the gut of Fc/R-deficient mice. To address this issue, commensal 
microbiota was reduced by oral treatment with antibiotics (Rakoff-Nahoum et al, 2004). 
As expected, serum IgA levels were down-regulated after antibiotics treatment in 
Fc/R-deficient mice (Fig. 2B). Moreover, IgA+ B cell population in PPs of 
Fc/R-deficient mice was comparable to those of control mice after antibiotics 
treatment (Fig. 2C). These results demonstrated that the increased IgA+ B cell 
population in PP of Fc/R-deficient mice was dependent on gut commensal 
microbiota.  
 
3.4  Fc/R expressed on FDCs negatively regulate serum IgA level. 
Fc/R was expressed most abundantly on FDCs, but also expressed on 
hematopoietic cells such as B cells and macrophages (Sakamoto et al, 2001). To 
determine the cell type responsible for the increased serum IgA level in 
Fc/R-deficient mice, we established bone marrow (BM) chimeric mice by 
transferring BM cells of Fc/R-deficient or control mice into lethally irradiated 
Fc/R-deficient or control mice. Since FDCs are radio-resistant cell population, FDCs 
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are derived from recipient mice, whereas hematopoietic cells of BM chimeric mice are 
derived from transferred BM cells. We observed that only BM chimeric mice, whose 
FDCs, but not hematopoietic cells, lack Fc/R expression, showed increased IgA in 
the sera (Fig. 3A). Thus, Fc/R on FDCs is involved in the increased serum IgA in 
response to gut-oriented antigens.   
 
3.5  Enhanced germinal center formation in response to commensal microbiota in 
Fc/R-deficient mice. 
Since FDCs contribute the generation of IgA+ B cell in germinal center (GC) 
of PP in the presence of commensal microbiota (Suzuki et al, 2010), we analyzed GC 
formation in Fc/R-deficient mice. Immunohistochemical analyses showed that 
CD21/35+ PNA+ GC area was enlarged in PPs of Fc/R-deficient mice compared with 
control mice (Fig. 3B). These results were confirmed by flow cytometry analyses, 
showing that GL7+PNA+ GC B cell population was larger in PP of Fc/R-deficient 
mice than in control mice (Fig. 3C). In addition, enhanced GC formation in PP of 
Fc/R-deficient mice was diminished after reduction of commensal microbiota by 
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antibiotics treatment (Fig. 3D and 3E). Thus, the increased serum IgA level in 
Fc/R-deficient mice seemed to result from increased germinal center formation in 
response to gut-oriented antigens.  
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3. Discussion 
We observed that naïve FcR-deficient mice on the (129 x B6) F1 
background, but not on the BALB/c or C57BL/6 genetic backgrounds, showed 
increased serum IgA level. It was previously reported that immune responses, including 
antibody production, are influenced by genetic background of mice (Dorf et al, 1974) 
(Lipes et al, 2002). Along with this notion, involvement of FcR in serum IgA level 
seemed to be influenced by the genetic background of mice. Although we found that 
Fc/R on FDCs was involved in the increased serum IgA (Fig. 3A), the expression of 
FcR on FDCs in PP was comparable among mice on the (129 x B6) F1, BALB/c 
and C57BL/6 genetic backgrounds (Fig. 1A and data not shown). Thus, differential 
involvement of FcR in serum IgA level in each mice strain could not be explained 
by FcR expression on FDCs in PP. The molecular basis for this phenomenon has 
remained unclear. 
   FcR and pIgR are receptors for both IgA and IgM, which were expressed 
in the intestine. In addition, their genes locate very closely on chromosome 1 (Shibuya 
et al, 2000). However, previous work demonstrated that FcR and pIgR are 
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differentially expressed in mucosal tissue, suggesting the different roles in this site 
(Wang et al, 2009). Although mice lacking pIgR showed impaired IgA clearance from 
the blood to the bile (Johansen et al, 1999), our analyses indicated that FcR does not 
contribute to IgA clearance from the blood. Rather, FcR seems to regulate serum 
IgA levels in response to gut-oriented antigens.  
IgA+ B cells are generated in the presence of IgA-CSR-inducing factors in PP, 
and among those factors, retinoic acid induces the expression of  integrin and 
CCR9 on B cells surface (Mora & von Andrian, 2009). IgA+ B cells then circulate 
through the bloodstream and home to the intestinal lamina propria via  and CCR9 
expression. In FcR-deficient mice, IgA+ B cells were increased in PP, but not in 
lamina propria, which is a dominant site for IgA production and secretion into feces. 
These results indicated that the generation of IgA+ B cells in PP was increased, whereas 
the homing of IgA+ B cells to lamina propria was not affected, in FcR-deficient mice. 
As a result, FcR-deficient mice showed increased serum IgA with normal fecal IgA 
in response to intestinal microbiota. Recently, it was reported that FDCs directly secrete 
IgA-CSR-inducing factors in response to gut microbiota for production of IgA+ B cells 
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in PP (Suzuki et al, 2010). We speculate that FcR on FDCs in mice on the (129 x 
B6) F1 genetic background regulates production of IgA-CSR-inducing factors, except 
retinoic acid, in response to gut-oriented antigens in PP. In addition to cytokine 
secretion, FDCs capture and retain antigens for B cells activation (Heesters et al, 2014). 
We have shown that the retention of systemic administered T-independent antigen on 
splenic FDCs was prolonged in the FcR-deficient mice (Honda et al, 2009). 
Therefore, we also speculate that retention of gut-oriented antigens on FDCs in PP is 
increased in the absence Fc/R, resulted in increased GC formation and IgA-CSR. The 
mechanisms how FcR on FDCs regulates production of IgA-CSR-inducing factors, 
and retention of gut-oriented antigens should be clarified in future.   
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Figure Legends 
Figure 1. Increased serum IgA in Fc/R-deficient mice. 
(A) Immunohistochemical analysis of Peyer’s patches of naïve Fc/R-deficient on the  
(129 x B6) F1 genetic background (-/-) and its littermate control (+/+). (B and C) IgA 
concentration of serum (B) and feces (C) of naive Fc/R-deficient and littermate 
control of the F1, BALB/c, or C57BL/6 genetic backgrounds. (D and E) 
Antigen-specific IgA titers in the serum (D) and feces (E) in -/- and +/+ mice after oral 
immunization with OVA or NP-LPS, respectively. (F) The serum IgA clearance in -/- 
and +/+ mice. n.s, not significant. 
 
Figure 2. Increased IgA+ B cell population in lymphoid organs of Fc/R-deficient 
mice. 
(A and C) IgA+ B cell populations of bone marrow (BM), spleen, mesenteric lymph 
node (MLN), Peyer’s patches (PP), peritoneum (PEC) and lamina propria (LP) in 
Fc/R-deficient (-/-) on the F1 genetic background and littermate control mice (+/+) 
before (A) and after (C) oral antibiotics treatment. Data are shown as percentages of 
24 
 
IgA+ B cells among total B220+ B cells. (B) IgA concentration in the serum of -/- and 
+/+ mice after oral antibiotics treatment. n.s, not significant. 
 
Figure 3. Fc/R on FDCs negatively regulates germinal center formation of PP. 
(A) Serum IgA concentration of naïve bone marrow chimeric mice, which were 
generated by transfer of bone marrow cells from Fc/R-deficient mice (-/-) on the F1 
genetic background or littermate control (+/+) into lethally irradiated -/- or +/+ mice. (B 
to E) Germinal center (GC) formation. Immunohistochemical analyses of PP of  or 
 mice before (B) and after (D) oral antibiotics treatment. The white arrowhead 
indicates GC. The flow cytometry analysis of PP cells obtained from  or  mice 
before (C) and after (E) oral antibiotics treatment. The percentage of GC B cells 
(GL7+PNA+B220+) among B cells (B220+) was shown. n.s, not significant. 
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